Malignant Digestive System Neoplasm — Trials

Malignant Digestive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,262
Recruiting: 2,364
Ph III recruiting: 291
Growth YoY: +12.1%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 28.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2,001)

clinicaltrialsPublishedShowing 551–600 of 1,391 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04796025	TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study(T-Double)	unknown	Phase 2	34	Sun Yat-sen UniversityOTHER	1	Sep 28, 2021	clinicaltrials
NCT04490694	TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma	unknown	Phase 2	54	Shanghai Zhongshan HospitalOTHER	1	Sep 24, 2021